^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
anti-PD-L1 CSR T cells
i
Other names: anti-PD-L1 CSR T cells, anti-PDL1 chimeric switch receptor modified T-cell therapy, autologous anti-PD-L1 CSR T cell therapy, autologous chimeric switch receptor modified T cell therapy, chimeric switch receptor engineered T cells redirected to PD-L1, CSR-T-PD-L1-cells, autologous CSR T, Chimeric Switch Receptor Modified T Cells, autologous anti-PD-L1 CSR T cell therapy
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Marino Biotech
Drug class:
PD-L1-targeted CAR-T immunotherapy
Related drugs:
